Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: November 2, 2017
Reporting Period: Third Quarter ended September 30, 2017
This filing serves to announce the Company's third-quarter 2017 results via a press release furnished as Exhibit 99.1, with corresponding financial figures in Exhibit 99.2.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached Exhibits (99.1 and 99.2) referenced in the report.
The Company utilizes the following non-GAAP financial measures to supplement IFRS results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Delivered Operating Income: Earnings before interest and taxes.
- Free Cash Flow.
Reconciliations between these non-GAAP measures and the most comparable IFRS measures are included in the attached press release and Cash Flow Statement.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. Specific performance comparisons are located in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
Management Commentary: The Company states that the inclusion of non-GAAP measures is intended to enhance user understanding of current financial performance and future prospects, while ensuring consistency and comparability with prior periods.
Regulatory Note: The Company emphasizes that these non-GAAP measures should not be used as a substitute for or considered superior to GAAP (IFRS) financial measures.
Legal Status of Exhibits: The attached exhibits are not deemed "filed" for purposes of Section 18 of the Exchange Act and are not subject to the liabilities of that section. They are not incorporated by reference in any other filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2017 revenue, profit, and cash flow figures.
- Examine Exhibit 99.2 for detailed financial tables and the reconciliation of non-GAAP measures to IFRS.
- Verify the specific definitions and calculations for EBITDA, delivered operating income, and free cash flow provided in the reconciliation statement.
- Check for any forward-looking statements or guidance updates contained within the press release text.